China NMPA Product Recall - Camera, endoscopic camera system, endoscopic camera, endoscopic camera device

Olympus Medical Corporation, through its subsidiary Olympus Trading (Shanghai) Co., Ltd., has initiated a voluntary Level II recall of several medical devices. This action, published by the National Medical Products Administration (NMPA) on November 17, 2023, addresses critical manufacturing and repair deficiencies. The recall involves various cameras, endoscopic camera systems, and endoscopic camera devices, identified by specific national medical device registration certificates. The primary issues stem from two distinct problems: the failure to adequately remove adhesive residue during the repair process of affected products, and the application of a sealant to unauthorized locations on certain cameras. These violations indicate a potential compromise in the product quality and safety standards. The NMPA's classification of this as a Level II recall signifies a situation where the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. Detailed information regarding the specific models, specifications, and batches subject to this recall is available in the "Medical Device Recall Event Report Form" submitted by Olympus. This proactive measure by Olympus under the NMPA's regulatory framework aims to mitigate potential risks to patients and healthcare professionals.